BIO-key Receives 2022 Govies Government Security Award from Security Today Magazine
Gold Recipient Award recognizes the PortalGuard® Platform for User Authentication/Identification/Credentialing and Management WALL, N.J., April…
4 years ago
Wire Stories
Cloud Security Innovator Sonrai Security Expands Globally into Europe and Asia-Pacific
Sonrai to offer its unique combination of identity, platform, data and workload security to enterprises…
4 years ago
APAC Pharmaceutical Contract Manufacturing Organization Market (2022 – 2027): Injectable Dose Formulations Holds Significant Market Share – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market - Growth, Trends, Forecasts (2022 - 2027)"…
4 years ago
China Elevator and Escalator Market Report (2022 to 2028) – Featuring Mitsubishi Electric, TK Elevator and Hitachi Among Others – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "China Elevator and Escalator - Market Size & Growth Forecast 2022-2028" report has…
4 years ago
AST SpaceMobile Announces Collaboration with Globe Telecom
Memorandum of Understanding Would Explore Opportunities to Extend AST SpaceMobile's Planned Coverage to Globe Telecom…
4 years ago
UMC Files Form 20-F for 2021 with US Securities and Exchange Commission
TAIPEI, Taiwan--(BUSINESS WIRE)--United Microelectronics Corporation (NYSE: UMC; TWSE: 2303) (“UMC”), today filed its 2021 annual…
4 years ago
WNS to Participate at Q2’22 Investor Conferences
NEW YORK & MUMBAI, India--(BUSINESS WIRE)--#BPM--WNS (Holdings) Limited (NYSE: WNS), a leading provider of global…
4 years ago
Zai Lab and Turning Point Therapeutics Announce Topline Analysis in China Subpopulation for Repotrectinib in ROS1-Positive NSCLC Cohorts Within Global Phase 1/2 TRIDENT-1 Study
91% confirmed objective response rate (cORR) (10/11) in China subpopulation by Blinded Independent Central Review…
4 years ago
Visteon Announces First-Quarter 2022 Results
VAN BUREN TOWNSHIP, Mich., April 28, 2022 (GLOBE NEWSWIRE) -- Visteon Corporation (NASDAQ: VC) today…
4 years ago
BeiGene Announces BRUKINSA (zanubrutinib) Approval in Uruguay in Mantle Cell Lymphoma, Marginal Zone Lymphoma, and Waldenström’s Macroglobulinemia
BRUKINSA is now available in four countries in Latin America, following previous approvals in Brazil,…
4 years ago